Home › Free Stock Grades › GRAL
GRAIL Inc. (GRAL) Stock Grade
GRAL · Healthcare
C
Market Cap
$5.7B
P/E Ratio
—
Revenue Growth (YoY)
+17.2%
Net Margin
-277.5%
Return on Equity
—
Dividend Yield
None
About GRAIL Inc.'s fundamentals
GRAIL Inc. is a healthcare diagnostics company with a market capitalization of $5.7 billion that generated 17.2% year-over-year revenue growth in its latest period. However, the company is currently unprofitable, reporting a net margin of -277.5% and a net loss in its most recent annual statement, indicating that expenses significantly exceed revenues. The company does not pay a dividend and lacks positive return on equity metrics, reflecting its pre-profitability stage as a diagnostic research firm.